According to Bloomberg, Johnson & Johnson continued selling a vaginal mesh implant for nine months after the U.S. Food and Drug Administration ordered the company to stop.
In a letter from August, 2007, the FDA told Johnson & Johnson to halt sales of Gynecare Prolift until the agency decided whether the device was “substantially equivalent” to other products on the market. The letter cited the “potential high risk for organ perforation” ...
continue reading...